Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer : The IP5-MATTER Study

Connor, M J, Genie, M, Dudderidge, T, Wu, H, Sukumar, J, Beresford, M, Bianchini, D, Goh, C, Horan, G, Innominato, P, Khoo, V, Klimowska-Nassar, N, Madaan, S, Mangar, S, McCracken, S, Ostler, P, Paisey, S, Robinson, A, Rai, B, Sarwar, N, Srihari, N, Jayaprakash, K T, Varughese, M, Winkler, M, Ahmed, H U, Watson, V & IP5-MATTER Trial Investigators 2025, 'Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer : The IP5-MATTER Study', European Urology Oncology, vol. 8, no. 3, pp. 663-673. https://doi.org/10.1016/j.euo.2024.06.010